English
简体中文
Total: £ 56.28
Published Date: 2026-03-12 | Pages: 117 | Tables: 114 | Medical Care
The global Cell and Gene Therapy market was valued at US$ 3580 million in 2025 and is anticipated to reach US$ 5713 million by 2032, at a CAGR of 6.9% from 2026 to 2032.
Cell and Gene Therapy is a revolutionary medical technology that treats or cures diseases by modifying or manipulating human genes. Its core lies in intervening at the root causes of genetic defects, cancer, and chronic diseases. This therapy is mainly divided into two categories: gene therapy focuses on delivering functionally normal genes into the patient's body via viral or non-viral vectors to replace or compensate for defective/abnormal genes, or to silence the expression of harmful genes; cell therapy involves modifying, activating, or expanding autologous or allogeneic live cells (such as immune cells and stem cells) in vitro and then reinfusing them to rebuild immune function, repair damaged tissue, or directly kill tumors. As a cutting-edge field of precision medicine, Cell and Gene Therapy offers potential cures for many diseases that traditional therapies have failed to address.
The global cell and gene therapy market is experiencing rapid growth driven by technological breakthroughs, a surge in pipelines, and commercialization. North America and Europe, as mature markets, lead in the number of approved CAR-T therapies, AAV gene therapies, and rare disease drugs, leveraging their advanced gene-editing technologies, robust regulatory frameworks, and extensive clinical research experience. The Asia-Pacific region is the fastest-growing and most active in clinical research. China, with its leading global number of cell therapy clinical studies, strong policy support, and cost advantages across its supply chain, is rapidly advancing autologous CAR-T, universal cell therapies, and gene-editing therapies, leading to the rapid rise of domestic innovative pharmaceutical companies. The industry as a whole is accelerating its evolution towards breakthroughs in solid tumors, universal off-the-shelf products, and in vivo gene editing.
This report delivers a comprehensive overview of the global Cell and Gene Therapy market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell and Gene Therapy. The Cell and Gene Therapy market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cell and Gene Therapy market comprehensively. Regional market sizes by Type, by Application, by Cell Source, and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cell and Gene Therapy manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Amgen Inc.
Dendreon Pharmaceuticals LLC.
Fibrocell Science, Inc
Lonza
Charles River Laboratories
Cytiva
Catalent Biologics
FUJIFILM Diosynth Biotechnologies
Made Scientific
AGC Biologics
Pfizer CentreOne
Samsung Biologics
Kite Pharma, Inc.
Kolon TissueGene, Inc.
Novartis AG
Segment by Type
Rare Diseases
Oncology
Hematology
Cardiovascular
Ophthalmology
Neurology
Others
Segment by Cell Source
Autologous Cell Therapy
Universal Cell Therapy
Xenogeneic Cell Therapy
Segment by Technology
Viral Vector Delivery
Non-viral Vector Delivery
Gene Editing Technology
Others
Segment by Application
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Contract Research Organizations (CROs)
Hospital
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, by Cell Source, etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cell and Gene Therapy companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cell and Gene Therapy Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Rare Diseases
1.2.3 Oncology
1.2.4 Hematology
1.2.5 Cardiovascular
1.2.6 Ophthalmology
1.2.7 Neurology
1.2.8 Others
1.3 Market by Cell Source
1.3.1 Global Cell and Gene Therapy Market Size Growth Rate by Cell Source: 2021 vs 2025 vs 2032
1.3.2 Autologous Cell Therapy
1.3.3 Universal Cell Therapy
1.3.4 Xenogeneic Cell Therapy
1.4 Market by Technology
1.4.1 Global Cell and Gene Therapy Market Size Growth Rate by Technology: 2021 vs 2025 vs 2032
1.4.2 Viral Vector Delivery
1.4.3 Non-viral Vector Delivery
1.4.4 Gene Editing Technology
1.4.5 Others
1.5 Market by Application
1.5.1 Global Cell and Gene Therapy Market Growth by Application: 2021 vs 2025 vs 2032
1.5.2 Pharmaceutical and Biotechnology Companies
1.5.3 Research and Academic Institutions
1.5.4 Contract Research Organizations (CROs)
1.5.5 Hospital
1.5.6 Others
1.6 Assumptions and Limitations
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends
2.1 Global Cell and Gene Therapy Market Perspective (2021–2032)
2.2 Global Cell and Gene Therapy Growth Trends by Region
2.2.1 Global Cell and Gene Therapy Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Cell and Gene Therapy Historic Market Size by Region (2021–2026)
2.2.3 Cell and Gene Therapy Forecasted Market Size by Region (2027–2032)
2.3 Cell and Gene Therapy Market Dynamics
2.3.1 Cell and Gene Therapy Industry Trends
2.3.2 Cell and Gene Therapy Market Drivers
2.3.3 Cell and Gene Therapy Market Challenges
2.3.4 Cell and Gene Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cell and Gene Therapy Players by Revenue
3.1.1 Global Top Cell and Gene Therapy Players by Revenue (2021–2026)
3.1.2 Global Cell and Gene Therapy Revenue Market Share by Players (2021–2026)
3.2 Global Top Cell and Gene Therapy Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Cell and Gene Therapy Revenue
3.4 Global Cell and Gene Therapy Market Concentration Ratio
3.4.1 Global Cell and Gene Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cell and Gene Therapy Revenue in 2025
3.5 Global Key Players of Cell and Gene Therapy Head Offices and Areas Served
3.6 Global Key Players of Cell and Gene Therapy, Products and Applications
3.7 Global Key Players of Cell and Gene Therapy, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Cell and Gene Therapy Breakdown Data by Type
4.1 Global Cell and Gene Therapy Historic Market Size by Type (2021–2026)
4.2 Global Cell and Gene Therapy Forecasted Market Size by Type (2027–2032)
5 Cell and Gene Therapy Breakdown Data by Application
5.1 Global Cell and Gene Therapy Historic Market Size by Application (2021–2026)
5.2 Global Cell and Gene Therapy Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Cell and Gene Therapy Market Size (2021–2032)
6.2 North America Cell and Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Cell and Gene Therapy Market Size by Country (2021–2026)
6.4 North America Cell and Gene Therapy Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cell and Gene Therapy Market Size (2021–2032)
7.2 Europe Cell and Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Cell and Gene Therapy Market Size by Country (2021–2026)
7.4 Europe Cell and Gene Therapy Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Cell and Gene Therapy Market Size (2021–2032)
8.2 Asia-Pacific Cell and Gene Therapy Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Cell and Gene Therapy Market Size by Region (2021–2026)
8.4 Asia-Pacific Cell and Gene Therapy Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Cell and Gene Therapy Market Size (2021–2032)
9.2 Latin America Cell and Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Cell and Gene Therapy Market Size by Country (2021–2026)
9.4 Latin America Cell and Gene Therapy Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cell and Gene Therapy Market Size (2021–2032)
10.2 Middle East & Africa Cell and Gene Therapy Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Cell and Gene Therapy Market Size by Country (2021–2026)
10.4 Middle East & Africa Cell and Gene Therapy Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Details
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Cell and Gene Therapy Introduction
11.1.4 Amgen Inc. Revenue in Cell and Gene Therapy Business (2021–2026)
11.1.5 Amgen Inc. Recent Development
11.2 Dendreon Pharmaceuticals LLC.
11.2.1 Dendreon Pharmaceuticals LLC. Company Details
11.2.2 Dendreon Pharmaceuticals LLC. Business Overview
11.2.3 Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Introduction
11.2.4 Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Business (2021–2026)
11.2.5 Dendreon Pharmaceuticals LLC. Recent Development
11.3 Fibrocell Science, Inc
11.3.1 Fibrocell Science, Inc Company Details
11.3.2 Fibrocell Science, Inc Business Overview
11.3.3 Fibrocell Science, Inc Cell and Gene Therapy Introduction
11.3.4 Fibrocell Science, Inc Revenue in Cell and Gene Therapy Business (2021–2026)
11.3.5 Fibrocell Science, Inc Recent Development
11.4 Lonza
11.4.1 Lonza Company Details
11.4.2 Lonza Business Overview
11.4.3 Lonza Cell and Gene Therapy Introduction
11.4.4 Lonza Revenue in Cell and Gene Therapy Business (2021–2026)
11.4.5 Lonza Recent Development
11.5 Charles River Laboratories
11.5.1 Charles River Laboratories Company Details
11.5.2 Charles River Laboratories Business Overview
11.5.3 Charles River Laboratories Cell and Gene Therapy Introduction
11.5.4 Charles River Laboratories Revenue in Cell and Gene Therapy Business (2021–2026)
11.5.5 Charles River Laboratories Recent Development
11.6 Cytiva
11.6.1 Cytiva Company Details
11.6.2 Cytiva Business Overview
11.6.3 Cytiva Cell and Gene Therapy Introduction
11.6.4 Cytiva Revenue in Cell and Gene Therapy Business (2021–2026)
11.6.5 Cytiva Recent Development
11.7 Catalent Biologics
11.7.1 Catalent Biologics Company Details
11.7.2 Catalent Biologics Business Overview
11.7.3 Catalent Biologics Cell and Gene Therapy Introduction
11.7.4 Catalent Biologics Revenue in Cell and Gene Therapy Business (2021–2026)
11.7.5 Catalent Biologics Recent Development
11.8 FUJIFILM Diosynth Biotechnologies
11.8.1 FUJIFILM Diosynth Biotechnologies Company Details
11.8.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.8.3 FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Introduction
11.8.4 FUJIFILM Diosynth Biotechnologies Revenue in Cell and Gene Therapy Business (2021–2026)
11.8.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.9 Made Scientific
11.9.1 Made Scientific Company Details
11.9.2 Made Scientific Business Overview
11.9.3 Made Scientific Cell and Gene Therapy Introduction
11.9.4 Made Scientific Revenue in Cell and Gene Therapy Business (2021–2026)
11.9.5 Made Scientific Recent Development
11.10 AGC Biologics
11.10.1 AGC Biologics Company Details
11.10.2 AGC Biologics Business Overview
11.10.3 AGC Biologics Cell and Gene Therapy Introduction
11.10.4 AGC Biologics Revenue in Cell and Gene Therapy Business (2021–2026)
11.10.5 AGC Biologics Recent Development
11.11 Pfizer CentreOne
11.11.1 Pfizer CentreOne Company Details
11.11.2 Pfizer CentreOne Business Overview
11.11.3 Pfizer CentreOne Cell and Gene Therapy Introduction
11.11.4 Pfizer CentreOne Revenue in Cell and Gene Therapy Business (2021–2026)
11.11.5 Pfizer CentreOne Recent Development
11.12 Samsung Biologics
11.12.1 Samsung Biologics Company Details
11.12.2 Samsung Biologics Business Overview
11.12.3 Samsung Biologics Cell and Gene Therapy Introduction
11.12.4 Samsung Biologics Revenue in Cell and Gene Therapy Business (2021–2026)
11.12.5 Samsung Biologics Recent Development
11.13 Kite Pharma, Inc.
11.13.1 Kite Pharma, Inc. Company Details
11.13.2 Kite Pharma, Inc. Business Overview
11.13.3 Kite Pharma, Inc. Cell and Gene Therapy Introduction
11.13.4 Kite Pharma, Inc. Revenue in Cell and Gene Therapy Business (2021–2026)
11.13.5 Kite Pharma, Inc. Recent Development
11.14 Kolon TissueGene, Inc.
11.14.1 Kolon TissueGene, Inc. Company Details
11.14.2 Kolon TissueGene, Inc. Business Overview
11.14.3 Kolon TissueGene, Inc. Cell and Gene Therapy Introduction
11.14.4 Kolon TissueGene, Inc. Revenue in Cell and Gene Therapy Business (2021–2026)
11.14.5 Kolon TissueGene, Inc. Recent Development
11.15 Novartis AG
11.15.1 Novartis AG Company Details
11.15.2 Novartis AG Business Overview
11.15.3 Novartis AG Cell and Gene Therapy Introduction
11.15.4 Novartis AG Revenue in Cell and Gene Therapy Business (2021–2026)
11.15.5 Novartis AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Cell and Gene Therapy Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Rare Diseases
Table 3. Key Players of Oncology
Table 4. Key Players of Hematology
Table 5. Key Players of Cardiovascular
Table 6. Key Players of Ophthalmology
Table 7. Key Players of Neurology
Table 8. Key Players of Others
Table 9. Global Cell and Gene Therapy Market Size Growth Rate by Cell Source (US$ Million): 2021 vs 2025 vs 2032
Table 10. Key Players of Autologous Cell Therapy
Table 11. Key Players of Universal Cell Therapy
Table 12. Key Players of Xenogeneic Cell Therapy
Table 13. Global Cell and Gene Therapy Market Size Growth Rate by Technology (US$ Million): 2021 vs 2025 vs 2032
Table 14. Key Players of Viral Vector Delivery
Table 15. Key Players of Non-viral Vector Delivery
Table 16. Key Players of Gene Editing Technology
Table 17. Key Players of Others
Table 18. Global Cell and Gene Therapy Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 19. Global Cell and Gene Therapy Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 20. Global Cell and Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 21. Global Cell and Gene Therapy Market Share by Region (2021–2026)
Table 22. Global Cell and Gene Therapy Forecasted Market Size by Region (US$ Million), 2027–2032
Table 23. Global Cell and Gene Therapy Market Share by Region (2027–2032)
Table 24. Cell and Gene Therapy Market Trends
Table 25. Cell and Gene Therapy Market Drivers
Table 26. Cell and Gene Therapy Market Challenges
Table 27. Cell and Gene Therapy Market Restraints
Table 28. Global Cell and Gene Therapy Revenue by Players (US$ Million), 2021–2026
Table 29. Global Cell and Gene Therapy Market Share by Players (2021–2026)
Table 30. Global Top Cell and Gene Therapy Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cell and Gene Therapy Revenue, 2025
Table 31. Ranking of Global Top Cell and Gene Therapy Companies by Revenue (US$ Million) in 2025
Table 32. Global 5 Largest Players Market Share by Cell and Gene Therapy Revenue (CR5 and HHI), 2021–2026
Table 33. Global Key Players of Cell and Gene Therapy, Headquarters and Area Served
Table 34. Global Key Players of Cell and Gene Therapy, Products and Applications
Table 35. Global Key Players of Cell and Gene Therapy, Date of General Availability (GA)
Table 36. Mergers and Acquisitions, Expansion Plans
Table 37. Global Cell and Gene Therapy Market Size by Type (US$ Million), 2021–2026
Table 38. Global Cell and Gene Therapy Revenue Market Share by Type (2021–2026)
Table 39. Global Cell and Gene Therapy Forecasted Market Size by Type (US$ Million), 2027–2032
Table 40. Global Cell and Gene Therapy Revenue Market Share by Type (2027–2032)
Table 41. Global Cell and Gene Therapy Market Size by Application (US$ Million), 2021–2026
Table 42. Global Cell and Gene Therapy Revenue Market Share by Application (2021–2026)
Table 43. Global Cell and Gene Therapy Forecasted Market Size by Application (US$ Million), 2027–2032
Table 44. Global Cell and Gene Therapy Revenue Market Share by Application (2027–2032)
Table 45. North America Cell and Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 46. North America Cell and Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 47. North America Cell and Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 48. Europe Cell and Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 49. Europe Cell and Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 50. Europe Cell and Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 51. Asia-Pacific Cell and Gene Therapy Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 52. Asia-Pacific Cell and Gene Therapy Market Size by Region (US$ Million), 2021–2026
Table 53. Asia-Pacific Cell and Gene Therapy Market Size by Region (US$ Million), 2027–2032
Table 54. Latin America Cell and Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 55. Latin America Cell and Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 56. Latin America Cell and Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 57. Middle East & Africa Cell and Gene Therapy Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 58. Middle East & Africa Cell and Gene Therapy Market Size by Country (US$ Million), 2021–2026
Table 59. Middle East & Africa Cell and Gene Therapy Market Size by Country (US$ Million), 2027–2032
Table 60. Amgen Inc. Company Details
Table 61. Amgen Inc. Business Overview
Table 62. Amgen Inc. Cell and Gene Therapy Product
Table 63. Amgen Inc. Revenue in Cell and Gene Therapy Business (US$ Million), 2021–2026
Table 64. Amgen Inc. Recent Development
Table 65. Dendreon Pharmaceuticals LLC. Company Details
Table 66. Dendreon Pharmaceuticals LLC. Business Overview
Table 67. Dendreon Pharmaceuticals LLC. Cell and Gene Therapy Product
Table 68. Dendreon Pharmaceuticals LLC. Revenue in Cell and Gene Therapy Business (US$ Million), 2021–2026
Table 69. Dendreon Pharmaceuticals LLC. Recent Development
Table 70. Fibrocell Science, Inc Company Details
Table 71. Fibrocell Science, Inc Business Overview
Table 72. Fibrocell Science, Inc Cell and Gene Therapy Product
Table 73. Fibrocell Science, Inc Revenue in Cell and Gene Therapy Business (US$ Million), 2021–2026
Table 74. Fibrocell Science, Inc Recent Development
Table 75. Lonza Company Details
Table 76. Lonza Business Overview
Table 77. Lonza Cell and Gene Therapy Product
Table 78. Lonza Revenue in Cell and Gene Therapy Business (US$ Million), 2021–2026
Table 79. Lonza Recent Development
Table 80. Charles River Laboratories Company Details
Table 81. Charles River Laboratories Business Overview
Table 82. Charles River Laboratories Cell and Gene Therapy Product
Table 83. Charles River Laboratories Revenue in Cell and Gene Therapy Business (US$ Million), 2021–2026
Table 84. Charles River Laboratories Recent Development
Table 85. Cytiva Company Details
Table 86. Cytiva Business Overview
Table 87. Cytiva Cell and Gene Therapy Product
Table 88. Cytiva Revenue in Cell and Gene Therapy Business (US$ Million), 2021–2026
Table 89. Cytiva Recent Development
Table 90. Catalent Biologics Company Details
Table 91. Catalent Biologics Business Overview
Table 92. Catalent Biologics Cell and Gene Therapy Product
Table 93. Catalent Biologics Revenue in Cell and Gene Therapy Business (US$ Million), 2021–2026
Table 94. Catalent Biologics Recent Development
Table 95. FUJIFILM Diosynth Biotechnologies Company Details
Table 96. FUJIFILM Diosynth Biotechnologies Business Overview
Table 97. FUJIFILM Diosynth Biotechnologies Cell and Gene Therapy Product
Table 98. FUJIFILM Diosynth Biotechnologies Revenue in Cell and Gene Therapy Business (US$ Million), 2021–2026
Table 99. FUJIFILM Diosynth Biotechnologies Recent Development
Table 100. Made Scientific Company Details
Table 101. Made Scientific Business Overview
Table 102. Made Scientific Cell and Gene Therapy Product
Table 103. Made Scientific Revenue in Cell and Gene Therapy Business (US$ Million), 2021–2026
Table 104. Made Scientific Recent Development
Table 105. AGC Biologics Company Details
Table 106. AGC Biologics Business Overview
Table 107. AGC Biologics Cell and Gene Therapy Product
Table 108. AGC Biologics Revenue in Cell and Gene Therapy Business (US$ Million), 2021–2026
Table 109. AGC Biologics Recent Development
Table 110. Pfizer CentreOne Company Details
Table 111. Pfizer CentreOne Business Overview
Table 112. Pfizer CentreOne Cell and Gene Therapy Product
Table 113. Pfizer CentreOne Revenue in Cell and Gene Therapy Business (US$ Million), 2021–2026
Table 114. Pfizer CentreOne Recent Development
Table 115. Samsung Biologics Company Details
Table 116. Samsung Biologics Business Overview
Table 117. Samsung Biologics Cell and Gene Therapy Product
Table 118. Samsung Biologics Revenue in Cell and Gene Therapy Business (US$ Million), 2021–2026
Table 119. Samsung Biologics Recent Development
Table 120. Kite Pharma, Inc. Company Details
Table 121. Kite Pharma, Inc. Business Overview
Table 122. Kite Pharma, Inc. Cell and Gene Therapy Product
Table 123. Kite Pharma, Inc. Revenue in Cell and Gene Therapy Business (US$ Million), 2021–2026
Table 124. Kite Pharma, Inc. Recent Development
Table 125. Kolon TissueGene, Inc. Company Details
Table 126. Kolon TissueGene, Inc. Business Overview
Table 127. Kolon TissueGene, Inc. Cell and Gene Therapy Product
Table 128. Kolon TissueGene, Inc. Revenue in Cell and Gene Therapy Business (US$ Million), 2021–2026
Table 129. Kolon TissueGene, Inc. Recent Development
Table 130. Novartis AG Company Details
Table 131. Novartis AG Business Overview
Table 132. Novartis AG Cell and Gene Therapy Product
Table 133. Novartis AG Revenue in Cell and Gene Therapy Business (US$ Million), 2021–2026
Table 134. Novartis AG Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources
Table 138. Authors List of This Report
List of Figures
Figure 1. Cell and Gene Therapy Picture
Figure 2. Global Cell and Gene Therapy Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Cell and Gene Therapy Market Share by Type: 2025 vs 2032
Figure 4. Rare Diseases Features
Figure 5. Oncology Features
Figure 6. Hematology Features
Figure 7. Cardiovascular Features
Figure 8. Ophthalmology Features
Figure 9. Neurology Features
Figure 10. Others Features
Figure 11. Global Cell and Gene Therapy Market Size Comparison by Cell Source (US$ Million), 2021–2032
Figure 12. Autologous Cell Therapy Features
Figure 13. Universal Cell Therapy Features
Figure 14. Xenogeneic Cell Therapy Features
Figure 15. Global Cell and Gene Therapy Market Size Comparison by Technology (US$ Million), 2021–2032
Figure 16. Viral Vector Delivery Features
Figure 17. Non-viral Vector Delivery Features
Figure 18. Gene Editing Technology Features
Figure 19. Others Features
Figure 20. Global Cell and Gene Therapy Market Size by Application (US$ Million), 2021–2032
Figure 21. Global Cell and Gene Therapy Market Share by Application: 2025 vs 2032
Figure 22. Pharmaceutical and Biotechnology Companies Case Studies
Figure 23. Research and Academic Institutions Case Studies
Figure 24. Contract Research Organizations (CROs) Case Studies
Figure 25. Hospital Case Studies
Figure 26. Others Case Studies
Figure 27. Cell and Gene Therapy Report Years Considered
Figure 28. Global Cell and Gene Therapy Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 29. Global Cell and Gene Therapy Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 30. Global Cell and Gene Therapy Market Share by Region: 2025 vs 2032
Figure 31. Global Cell and Gene Therapy Market Share by Players in 2025
Figure 32. Global Cell and Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 33. The Top 10 and 5 Players Market Share by Cell and Gene Therapy Revenue in 2025
Figure 34. North America Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. North America Cell and Gene Therapy Market Share by Country (2021–2032)
Figure 36. United States Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Canada Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Europe Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Europe Cell and Gene Therapy Market Share by Country (2021–2032)
Figure 40. Germany Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. France Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. U.K. Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Italy Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 44. Russia Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Ireland Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. Asia-Pacific Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Asia-Pacific Cell and Gene Therapy Market Share by Region (2021–2032)
Figure 48. China Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 49. Japan Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 50. South Korea Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 51. Southeast Asia Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 52. India Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 53. Australia & New Zealand Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 54. Latin America Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 55. Latin America Cell and Gene Therapy Market Share by Country (2021–2032)
Figure 56. Mexico Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 57. Brazil Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 58. Middle East & Africa Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 59. Middle East & Africa Cell and Gene Therapy Market Share by Country (2021–2032)
Figure 60. Israel Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 61. Saudi Arabia Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 62. UAE Cell and Gene Therapy Market Size YoY Growth (US$ Million), 2021–2032
Figure 63. Amgen Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2021–2026)
Figure 64. Dendreon Pharmaceuticals LLC. Revenue Growth Rate in Cell and Gene Therapy Business (2021–2026)
Figure 65. Fibrocell Science, Inc Revenue Growth Rate in Cell and Gene Therapy Business (2021–2026)
Figure 66. Lonza Revenue Growth Rate in Cell and Gene Therapy Business (2021–2026)
Figure 67. Charles River Laboratories Revenue Growth Rate in Cell and Gene Therapy Business (2021–2026)
Figure 68. Cytiva Revenue Growth Rate in Cell and Gene Therapy Business (2021–2026)
Figure 69. Catalent Biologics Revenue Growth Rate in Cell and Gene Therapy Business (2021–2026)
Figure 70. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Cell and Gene Therapy Business (2021–2026)
Figure 71. Made Scientific Revenue Growth Rate in Cell and Gene Therapy Business (2021–2026)
Figure 72. AGC Biologics Revenue Growth Rate in Cell and Gene Therapy Business (2021–2026)
Figure 73. Pfizer CentreOne Revenue Growth Rate in Cell and Gene Therapy Business (2021–2026)
Figure 74. Samsung Biologics Revenue Growth Rate in Cell and Gene Therapy Business (2021–2026)
Figure 75. Kite Pharma, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2021–2026)
Figure 76. Kolon TissueGene, Inc. Revenue Growth Rate in Cell and Gene Therapy Business (2021–2026)
Figure 77. Novartis AG Revenue Growth Rate in Cell and Gene Therapy Business (2021–2026)
Figure 78. Bottom-up and Top-down Approaches for This Report
Figure 79. Data Triangulation
Figure 80. Key Executives Interviewed
